Completed NA INTERVENTIONAL NCT00192855

Entacapone Augmentation for Schizophrenia

Entacapone Augmentation for Schizophrenia- A Randomized Controlled Trial

Sponsor: Rambam Health Care Campus

Interventions Entacapone

Updated 5 times since 2017 Last updated: Aug 24, 2010 Started: Jun 30, 2003 Primary completion: Oct 31, 2006 Completion: Oct 31, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Schizophrenia and is currently completed. Rambam Health Care Campus leads this study, which shows 5 recorded versions since 2003 — indicating limited longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Jun 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Rambam Health Care Campus

Data source: Rambam Health Care Campus

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Haifa, Israel